Dalgety is a UK market leader in the production of high-quality pharmaceutical cannabis for distribution to the medical industry.
Founded in the UK in 2016, Dalgety is dedicated to the research and development of the highest-grade product, with consistent levels of cannabinoids for prescription medicines. Overseen by world leading experts in biochemistry and horticulture, our state-of-the-art facility combines human-led techniques with AI controlled management for the very best growing and processing practices.
Following the UK government permitting the use of prescription medical cannabis in 2018, Dalgety is ideally positioned as a UK producer for distribution directly to the medical market.
We believe that cannabis has a significant role to play in the treatment of many chronic and acute medical conditions. It has been used as a natural remedy by diverse cultures for over 10,000 years. Scientific study is ongoing into the multiple uses and conditions that cannabinoids can relieve. Only recently has it been possible to identify and extract the individual active ingredients for research to identify any benefits for a wide range of medical conditions.
Our aim is to produce consistently high-quality ingredients through environmentally controlled hydroponic growing and pharmaceutical grade manufacturing processes and be recognised as the leading supplier to the medical community.
The medical cannabis market operates under very strict regulation by Government and Medical Product Regulators. Dalgety is fully compliant and works closely with the Home Office and the Medicines & Healthcare Products Regulatory Agency (MHRA) to maintain the highest of standards.